To evaluate the safety and early bactericidal activity of AZD5847 in subjects with sputum smear-positive pulmonary tuberculosis to better assess the potential role of this compound in TB treatment. To ...
Mechanism for platelet reduction in anti-neuropilin-1 (MNRP1685A)–treated phase I patients. This is an ASCO Meeting Abstract from the 2011 ASCO Annual Meeting I. This abstract does not include a full ...
“I’m not a nerd, d’you know what I mean?” Darren Cunningham, the electronic artist known as Actress, is discussing the gaps in his knowledge of the ancient instruments, relics of the birth of techno ...
About 30%-40% of triple-negative breast cancers (TNBC) show HER2-low status and may benefit from the HER2-directed antibody-drug conjugate trastuzumab deruxtecan (T-DXd). Ataxia-telangiectasia mutated ...
Researchers from Astrazeneca plc presented the structure and preclinical characterization of a novel PCSK9 inhibitor, AZD-0780, being developed for the treatment of cardiovascular disease. A new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results